Agonista-antagonista (Spanish Wikipedia)

Analysis of information sources in references of the Wikipedia article "Agonista-antagonista" in Spanish language version.

refsWebsite

Global rank Spanish rank

10doi.org

2^nd place

9nih.gov

4^th place

2archive.org

6^th place

5^th place

1acs.org

1,248^th place

1,054^th place

1issn.org

57^th place

3^rd place

acs.org

pubs.acs.org

Ferracane, Michael J.; Brice-Tutt, Ariana C.; Coleman, Jeremy S.; Simpson, Grant G.; Wilson, Lisa L.; Eans, Shainnel O.; Stacy, Heather M.; Murray, Thomas F. et al. (6 de abril de 2020). «Design, Synthesis, and Characterization of the Macrocyclic Tetrapeptide cyclo[Pro-Sar-Phe-d-Phe]: A Mixed Opioid Receptor Agonist–Antagonist Following Oral Administration». ACS Chemical Neuroscience 11 (9): 1324-1336. ISSN 1948-7193. doi:10.1021/acschemneuro.0c00086.

archive.org

«Benefit-risk ratio of agonist-antagonist analgesics». Drug and Alcohol Dependence 20 (4): 385-93. December 1987. PMID 2894291. doi:10.1111/j.1360-0443.1989.tb00595.x.
«Simultaneous targeting of multiple opioid receptors: a strategy to improve side-effect profile». British Journal of Anaesthesia 103 (1): 38-49. July 2009. PMID 19474215. doi:10.1093/bja/aep129.

doi.org

dx.doi.org

«Opioid agonist-antagonist drugs in acute and chronic pain states». Drugs 41 (3): 326-44. March 1991. PMID 1711441. doi:10.2165/00003495-199141030-00002.
«Alpha2-adrenoreceptors profile modulation. 3.1 (R)-(+)-m-nitrobiphenyline, a new efficient and alpha2C-subtype selective agonist». Journal of Medicinal Chemistry 50 (16): 3964-8. August 2007. PMID 17630725. doi:10.1021/jm061487a.
«Fruitful adrenergic α(2C)-agonism/α(2A)-antagonism combination to prevent and contrast morphine tolerance and dependence». Journal of Medicinal Chemistry 53 (21): 7825-35. November 2010. PMID 20925410. doi:10.1021/jm100977d.
Hollister, Leo E. (17 de julio de 1991). «AMA Drug Evaluations Annual 1991». JAMA: The Journal of the American Medical Association 266 (3): 97. doi:10.1001/jama.1991.03470030126039.
«Butorphanol: effects of a prototypical agonist-antagonist analgesic on kappa-opioid receptors». Journal of Pharmacological Sciences 98 (2): 109-16. June 2005. PMID 15942128. doi:10.1254/jphs.CRJ05001X.
«Nalbuphine». Drug and Alcohol Dependence 14 (3–4): 339-62. February 1985. PMID 2986929. doi:10.1016/0376-8716(85)90066-3.
Ferracane, Michael J.; Brice-Tutt, Ariana C.; Coleman, Jeremy S.; Simpson, Grant G.; Wilson, Lisa L.; Eans, Shainnel O.; Stacy, Heather M.; Murray, Thomas F. et al. (6 de abril de 2020). «Design, Synthesis, and Characterization of the Macrocyclic Tetrapeptide cyclo[Pro-Sar-Phe-d-Phe]: A Mixed Opioid Receptor Agonist–Antagonist Following Oral Administration». ACS Chemical Neuroscience 11 (9): 1324-1336. ISSN 1948-7193. doi:10.1021/acschemneuro.0c00086.
Benson GJ, Tranquilli WJ (March 1992). «Advantages and guidelines for using opioid agonist-antagonist analgesics». The Veterinary Clinics of North America. Small Animal Practice 22 (2): 363-5. PMID 1585578. doi:10.1016/S0195-5616(92)50637-4.
«Benefit-risk ratio of agonist-antagonist analgesics». Drug and Alcohol Dependence 20 (4): 385-93. December 1987. PMID 2894291. doi:10.1111/j.1360-0443.1989.tb00595.x.
«Simultaneous targeting of multiple opioid receptors: a strategy to improve side-effect profile». British Journal of Anaesthesia 103 (1): 38-49. July 2009. PMID 19474215. doi:10.1093/bja/aep129.

issn.org

portal.issn.org

Ferracane, Michael J.; Brice-Tutt, Ariana C.; Coleman, Jeremy S.; Simpson, Grant G.; Wilson, Lisa L.; Eans, Shainnel O.; Stacy, Heather M.; Murray, Thomas F. et al. (6 de abril de 2020). «Design, Synthesis, and Characterization of the Macrocyclic Tetrapeptide cyclo[Pro-Sar-Phe-d-Phe]: A Mixed Opioid Receptor Agonist–Antagonist Following Oral Administration». ACS Chemical Neuroscience 11 (9): 1324-1336. ISSN 1948-7193. doi:10.1021/acschemneuro.0c00086.

nih.gov

ncbi.nlm.nih.gov

«Opioid agonist-antagonist drugs in acute and chronic pain states». Drugs 41 (3): 326-44. March 1991. PMID 1711441. doi:10.2165/00003495-199141030-00002.
«Alpha2-adrenoreceptors profile modulation. 3.1 (R)-(+)-m-nitrobiphenyline, a new efficient and alpha2C-subtype selective agonist». Journal of Medicinal Chemistry 50 (16): 3964-8. August 2007. PMID 17630725. doi:10.1021/jm061487a.
«Fruitful adrenergic α(2C)-agonism/α(2A)-antagonism combination to prevent and contrast morphine tolerance and dependence». Journal of Medicinal Chemistry 53 (21): 7825-35. November 2010. PMID 20925410. doi:10.1021/jm100977d.
«Butorphanol: effects of a prototypical agonist-antagonist analgesic on kappa-opioid receptors». Journal of Pharmacological Sciences 98 (2): 109-16. June 2005. PMID 15942128. doi:10.1254/jphs.CRJ05001X.
«Nalbuphine». Drug and Alcohol Dependence 14 (3–4): 339-62. February 1985. PMID 2986929. doi:10.1016/0376-8716(85)90066-3.
Buprenorphine. StatPearls Publishing. 2019. PMID 29083570.
Benson GJ, Tranquilli WJ (March 1992). «Advantages and guidelines for using opioid agonist-antagonist analgesics». The Veterinary Clinics of North America. Small Animal Practice 22 (2): 363-5. PMID 1585578. doi:10.1016/S0195-5616(92)50637-4.
«Benefit-risk ratio of agonist-antagonist analgesics». Drug and Alcohol Dependence 20 (4): 385-93. December 1987. PMID 2894291. doi:10.1111/j.1360-0443.1989.tb00595.x.
«Simultaneous targeting of multiple opioid receptors: a strategy to improve side-effect profile». British Journal of Anaesthesia 103 (1): 38-49. July 2009. PMID 19474215. doi:10.1093/bja/aep129.